{"id":2093,"date":"2019-08-10T11:46:15","date_gmt":"2019-08-10T09:46:15","guid":{"rendered":"http:\/\/www.blog.asmus-puhl.com\/?p=2093"},"modified":"2019-08-10T11:46:15","modified_gmt":"2019-08-10T09:46:15","slug":"colfax-released-decent-q2-2019-results","status":"publish","type":"post","link":"http:\/\/www.blog.asmus-puhl.com\/?p=2093","title":{"rendered":"Colfax released decent Q2 2019 results"},"content":{"rendered":"\n<p>Colfax Corp. (NYSE:CFX) our conglomerate in transition since it acquired the medical device sector <a href=\"https:\/\/finance.yahoo.com\/news\/colfax-reports-second-quarter-2019-103000171.html\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"released Q2 2019 results. (opens in a new tab)\">released Q2 2019 results.<\/a><\/p>\n\n\n\n<p>The\nmedical device sector grew sales by 3%, fabrication technology grew\nsales by 6%.<\/p>\n\n\n\n<p>Net\nloss in the quarter was $466.6 million or $3.45 per share, which\nincludes a non-cash charge of $3.48 per share for the pending\ndivestiture of its Air &amp; Gas Handling business that is mostly\nattributable to the recognition of cumulative foreign currency\ntranslation effects from the long-term strengthening of the U.S.\nDollar. \n<\/p>\n\n\n\n<p>Excluding\nthe divestiture impacts, strategic transaction costs, restructuring\nexpenses and acquisition-related amortization costs, Colfax reported\nfully consolidated adjusted net income of $0.64 per share in the\nsecond quarter 2019 versus $0.61 in the second quarter of 2018.\n\n<\/p>\n\n\n\n<p>Colfax\ncontinues to expect its businesses to achieve the previously\nannounced 2019 adjusted EPS guidance of $1.90 to $2.00 from\ncontinuing operations.<\/p>\n\n\n\n<p>Those\nnumbers came in better than expected by the market and the stock\njumped 15% on Wednesday.<\/p>\n\n\n\n<p>But\nover the long term it is clearly visible that Colfax Corp. remains a\nslow grower and the development of the stock price reflects that.<\/p>\n\n\n\n<p>Q2\nnumbers show that the divestiture of the Air &amp; Gas Handling\nsector and the acquisition of the medical device unit did not improve\ngrowth rates. And most probably this will not change in the future! \n<\/p>\n\n\n\n<p>One just has to watch Johnson &amp; Johnson (NYSE:JNJ) with its growth problem in the medical device section. But they have a strong pharmaceutical section which drives the growth.<\/p>\n\n\n\n<p>Therefore we recommend to sell Colfax shares now! There are more interesting investment opportunities in the stock market!<\/p>\n\n\n\n<p>This\nblog follows Colfax Corp. since May 2009 when the share price of\nColfax stood at $7.27<\/p>\n\n\n\n<p>Readers\nwho bought at that time can now realize a capital gain of 258% at a\nstock price of $26 &#8211; not so bad!<\/p>\n\n\n\n<p>This\nblog will stop following Colfax and start to follow another more\ninteresting stock soon!<\/p>\n\n\n\n<p>So\nstay tuned!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Colfax Corp. (NYSE:CFX) our conglomerate in transition since it acquired the medical device sector released Q2 2019 results. The medical device sector grew sales by 3%, fabrication technology grew sales by 6%. Net loss in the quarter was $466.6 million or $3.45 per share, which includes a non-cash charge of $3.48 per share for the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=\/wp\/v2\/posts\/2093"}],"collection":[{"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2093"}],"version-history":[{"count":2,"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=\/wp\/v2\/posts\/2093\/revisions"}],"predecessor-version":[{"id":2095,"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=\/wp\/v2\/posts\/2093\/revisions\/2095"}],"wp:attachment":[{"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2093"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.blog.asmus-puhl.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}